Friday December 15, 2017
Home India Delhi governm...

Delhi government to probe dengue death row

0
35
Rout family. Photo Credit: http://indianexpress.com

By NewsGram Staff-Writer

The Delhi government will soon announce a magisterial inquiry into the 7-year-old Avinash Rout’s death considering the outrage that broke out after the same, according to reports.

Rout family. Photo Credit: http://indianexpress.com
Rout family. Photo Credit: http://indianexpress.com

The boy died of dengue this week after being denied admission to five hospitals in the city. He was admitted to a hospital in Tughlakabad later where he died on the 8th of September.

After cremating Avinash’s body, his parents jumped off the terrace of a four storey building.

According to relatives and friends, the government would be looking into the CCTV footage of the hospitals wherein Avinash was rejected medical help. Avinash was refused admission on September 7 to five hospitals.

A senior official said, “On Saturday, the government took Avinash’s treatment record from Batra hospital. The 50-page record also includes a case history from his treating doctor. It stated that the family had been referred from five private hospitals and mentioned their names. This is based on what the parents told doctors while admitting their son,” as quoted in the leading daily.

He further added that show-cause notices were issued to the hospitals only after the records were thoroughly checked.

The five hospitals — Moolchand, Max Saket, Akash hospital, Irene hospital, and Saket City hospital — were issued show-cause notices on Saturday seeking the reasons as to why the registration of the aforementioned hospitals should not be cancelled said the director of health services Sunil Bhatnagar.

The notice also asked as to why the hospital refuted the Delhi government’s order on August 28 to not deny admission to any dengue patient on account of lack of beds.

According to sources after Avinash’s treatment records will be looked over by the top Delhi government officials, matters of the probe would be submitted for a magisterial inquiry.

Max and Saket City hospitals said Avinash had not been treated in their emergency wards. “The CCTV footage will be the only way to corroborate these claims. Since the parents are dead, we will have to contact friends and relatives. This might be possible only under a magisterial probe,” explained the official, as quoted in a leading daily.

Next Story

Delhi records 3,829 cases of dengue, 502 of chikungunya till date

The year 2015 had reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

0
27
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

New Delhi, November 7, 2017 :  Delhi has so far recorded 3,829 cases of dengue and 502 cases of chikungunya, according to civic agencies on Monday.

While the national capital has witnessed a total of four dengue-related deaths till now, no deaths have been reported due to chikungunya.

ALSO READ You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

The year 2015 reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

As for chikungunya, 2016 saw 7,117 cases — the highest in the last five years.

Civic agencies said that areas under the South Delhi Municipal Corporation reported the maximum cases of chikungunya and dengue this year.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

Delhi has also reported a total of 552 malaria cases with no deaths so far. The figure is the second-highest after 2012 when the cases had soared to 822. (IANS)

Next Story

You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease

0
65
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

Roorkee, October 9, 2017 : Dengue and Chikungunya are known to strike fear in the country every year, so much so that the health graph of the city registers a steep rise in these cases. Both of the water-borne diseases, characterized by high fever and pain in the joints, take a toll on our lives. So far, there is no vaccine to immunize people against the spread of the Dengue and Chikungunya virus. However, researchers at IIT-Roorkee have now discovered that a commonly-utilized de-worming drug can be efficiently used for treatments against Chikungunya.

According to a report by PTI, Shailly Tomar, lead researcher and a professor at Indian Institute of Technology (IIT) Roorkee in Uttarakhand was quoted as saying, “Our research has shown that piperazine, a drug existing in the market, is successful in curbing the spread and replication of the Chikungunya virus in a lab setting.”

The drug, Piperazine, is usually used in de-worming treatments against round-words and pinworms. Using their expertise in virology and structure biology, experts have now discovered the anti-viral capabilities of the drug that can potentially prompt new therapies against the fatal, mosquito borne disease.

The researchers are currently testing the molecule on animals, and will consequently take it to clinical trials.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

The molecular details uncovered in the study, which has been published in the journal Antiviral Research, will be additionally used to plan piperazine-derivative medications that are more compelling to fight against the Chikungunya virus.

Using X-ray crystallographic technique, in combination with computational science and fluorescence strategies, the researchers discovered that piperazine binds itself with the hydrophobic (water-hating) pocket of capsid protein present in the Chikungunya virus, which can reduce the spread of the virus.

“This pocket is key to the replication of the virus and its spread inside a host. Inhibiting the pocket prevents budding and spread of the virus and can help in treating the virus effectively using existing drugs,” Tomar said.

Chikungunya has become a major public health concern, with an increasing number of people being plagued by the disease every year.

 At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease. 

Developing a new anti-viral drug molecule can take up to 10 years. To tend to the disease on an immediate basis, Professor Tomar added, “We are looking at repositioning existing, approved drugs and testing these to see if they might inhibit or kill pathogenic viruses.”

 

 

Next Story

Central government hospitals in India to reserve beds for Dengue, Chikungunya

At least 14 people have died in the national capital since the outbreak of the vector-borne disease in last a few days

3
134
Mosquito. Wikimedia

NEW DELHI, Sept 16, 2016: The central government has agreed to reserve 10 percent of the beds in its hospitals for treatment of dengue and chikungunya patients, according to Delhi Health Minister Satyendar Jain.

Jain’s remarks came after meeting Union Health Minister J.P. Nadda at his office here on Friday.

“We had requested Mr Nadda to reserve at least 10 percent beds (1,000 beds) in the central government-run hospitals, like All India Institute of Medical Sciences (AIIMS), Safdarjung Hospital, Ram Manohar Lohia Hospital, etc., for treatment of dengue and chikungunya cases, to which he (Nadda) agreed,” Jain told reporters after the meeting.

Earlier, Jain had sought an appointment with Nadda and also written him a letter requesting the Union Minister to convene a meeting of the health ministers of neighbouring states.

Follow NewsGram on Facebook

AIIMS. Wikimedia
AIIMS. Wikimedia

He urged Nadda to ask health ministers of neighbouring states like Uttar Pradesh and Haryana to set up fever clinics in order to reduce excessive patient inflow in the hospitals of Delhi.

“The government should also advertise about these fever clinics, so that people could know about it,” he added.

Asked whether Delhi will take patients from other states, Jain said, “We are not denying treatment to anybody coming to Delhi For treatment.”

Follow NewsGram on Twitter

He also said that in Delhi government hospitals more than 1,500 beds are available, and there is no need for panic. “We are working day and night,” he added.

At least 14 people have died in the national capital since the outbreak of the vector-borne disease in last a few days. (IANS)